Cardiovascular diseases in patients with rheumatoid arthritis during long-term methotrexate therapy
AIM: To compare the prevalence of risk factors, clinical and subclinical manifestations of cardiovascular diseases (CVD) and their complications in methotrexate (MT)-treated and untreated patients with rheumatoid arthritis/MATERIAL AND METHODS: The investigation enrolled 193 patients (168 women and...
Main Authors: | E V Gerasimova, T V Popkova, D S Novikova, E L Nasonov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2014-05-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/31472 |
Similar Items
-
Higher Risk of Cardiovascular Diseases in Rheumatoid Arthritis Patients Without Methotrexate Treatment
by: Karel Hloch, et al.
Published: (2021-11-01) -
Methotrexate use, not interleukin 33, is associated with lower carotid intima-media thickness in patients with rheumatoid arthritis
by: Maria Raquel Costa Pinto, et al.
Published: (2019-04-01) -
Ten-year risk of cardiovascular complications in patients with rheumatoid arthritis
by: Elena Vladimirovna Gerasimova, et al.
Published: (2011-05-01) -
Methotrexate in Treatment of Rheumatoid Arthritis
by: Wiewiόrowski Maciej, et al.
Published: (1999-08-01) -
METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
by: E. L. Nasonov
Published: (2016-12-01)